Sep 13, 2024FDA Grants Orphan Drug Designation to Opaganib in NeuroblastomaThe FDA has granted a second orphan drug designation to opaganib in oncology, this time for patients with neuroblastoma.Read more: https://www.targetedonc.com/view/fda-grants-orphan-drug-designation-to-opaganib-in-neuroblastoma
The FDA has granted a second orphan drug designation to opaganib in oncology, this time for patients with neuroblastoma.Read more: https://www.targetedonc.com/view/fda-grants-orphan-drug-designation-to-opaganib-in-neuroblastoma
Comentários